Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 9/2020

01-09-2020 | Diseases of the neuromuscular synapses and muscles | Myocardial Disease (A Abbate and G Sinagra, Section Editors)

Left Ventricular Noncompaction Syndrome: Genetic Insights and Therapeutic Perspectives

Authors: Josef Finsterer, Claudia Stöllberger

Published in: Current Cardiology Reports | Issue 9/2020

Login to get access

Abstract

Purpose of Review

To discuss the association of left ventricular hypertrabeculation/noncompaction (LVHT/LVNC/NCCM) with genetic disease and to outline the therapeutic options for non-symptomatic and symptomatic LVHT.

Recent Findings

A number of new mutated genes have been recently detected being associated with LVHT. There are indications that microtubules changing cell polarity, the transcription factor Nkx2-5, and NOTCH-1 signaling are involved in the pathogenesis of LVHT. There are also indications that the PKC signaling pathway, which is involved in the regulation of gap junction intercellular communication, is disturbed in LVHT.

Summary

LVHT is the same as LVNC and is associated with pathogenic variants in > 110 mtDNA or nDNA genes. LVHT has been also reported in > 15 chromosomal defects. However, a causal relation between any of these variants and LVHT has not been proven. There is no general agreement on the treatment of LVHT. According to expert opinions, LVHT patients require anticoagulation if they meet the criteria for anticoagulation or an ICD if they meet the appropriate criteria. Heart failure therapy is equal to patients with other causes of heart failure.
Literature
1.•
Finsterer J, Stöllberger C, Towbin JA. Left ventricular noncompaction cardiomyopathy: cardiac, neuromuscular, and genetic factors. Nat Rev Cardiol. 2017;14:224–37. Comprehensive review about the etiology, pathophysiology, diagnosis, and treatment of the phenomenon.
2.
Finsterer J. Cardiogenetics, neurogenetics, and pathogenetics of left ventricular hypertrabeculation/noncompaction. Pediatr Cardiol. 2009;30:659–81.PubMed
3.
Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;82:507–13.PubMed
4.
Oechslin E, Jenni R. Left Ventricular Noncompaction: From Physiologic Remodeling to Noncompaction Cardiomyopathy. J Am Coll Cardiol. 2018;71:723–6.PubMed
5.
Stöllberger C, Gerecke B, Finsterer J, Engberding R. Refinement of echocardiographic criteria for left ventricular noncompaction. Int J Cardiol. 2013;165:463–7.PubMed
6.
Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol. 2005;46:101–5.PubMed
7.
Jacquier A, Thuny F, Jop B, Giorgi R, Cohen F, Gaubert JY, et al. Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction. Eur Heart J. 2010;31:1098–104.PubMed
8.
Thakur V, Jaeggi ET, Nield LE. A unique foetal case of left ventricular non-compaction associated with arrhythmia, structural cardiac anomalies, and agenesis of the ductus venosus. Cardiol Young. 2016;26:368–70.PubMed
9.
Liu Y, Chen H, Shou W. Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC). Pediatr Cardiol. 2018;39:1099–106.PubMedPubMedCentral
10.
Moorman AF, Christoffels VM. Cardiac chamber formation: development, genes, and evolution. Physiol Rev. 2003;83:1223–67.PubMed
11.
Grego-Bessa J, Luna-Zurita L, del Monte G, Bolós V, Melgar P, Arandilla A, et al. Notch signaling is essential for ventricular chamber development. Dev Cell. 2007;12:415–29.PubMedPubMedCentral
12.
Stankunas K, Hang CT, Tsun ZY, Chen H, Lee NV, Wu JI, et al. Endocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesis. Dev Cell. 2008;14:298–311.PubMedPubMedCentral
13.
Lai D, Liu X, Forrai A, Wolstein O, Michalicek J, Ahmed I, et al. Neuregulin 1 sustains the gene regulatory network in both trabecular and nontrabecular myocardium. Circ Res. 2010;107:715–27.PubMed
14.
Luxán G, Casanova JC, Martínez-Poveda B, Prados B, D'Amato G, MacGrogan D, et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med. 2013;19:193–201.PubMed
15.
16.••
Choquet C, Nguyen THM, Sicard P, Buttigieg E, Tran TT, Kober F, et al. Deletion of Nkx2-5 in trabecular myocardium reveals the developmental origins of pathological heterogeneity associated with ventricular non-compaction cardiomyopathy. PLoS Genet. 2018;14, e1007502. https://​doi.​org/​10.​1371/​journal.​pgen.​1007502. Provides insights into the mechanism by which the transcription factor Nkx2-5 causes hypertrabeculation in mice.
17.••
Del Monte-Nieto G, Ramialison M, Adam AAS, Wu B, Aharonov A, D'Uva G, et al. Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. Nature. 2018;557:439–45. Provides insights into the myocardial development mediated by NOTCH1 signaling.
18.
Xie Y, Liu S, Hu S, Wei Y. Cardiomyopathy-Associated Gene 1-Sensitive PKC-Dependent Connexin 43 Expression and Phosphorylation in Left Ventricular Noncompaction Cardiomyopathy. Cell Physiol Biochem. 2017;44:828–42.PubMed
19.
20.
Gati S, Papadakis M, Papamichael ND, Zaidi A, Sheikh N, Reed M, et al. Reversible de novo left ventricular trabeculations in pregnant women: implications for the diagnosis of left ventricular noncompaction in low-risk populations. Circulation. 2014;130:475–83.PubMed
21.
Gati S, Chandra N, Bennett RL, Reed M, Kervio G, Panoulas VF, et al. Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes? Heart. 2013;99:401–8.PubMed
22.
Finsterer J, Stöllberger C, Fazio G. Neuromuscular disorders in left ventricular hypertrabeculation/noncompaction. Curr Pharm Des. 2010;16:2895–904.PubMed
23.
Finsterer J, Stöllberger C, Wegmann R, Janssen LA. Acquired left ventricular hypertrabeculation/noncompaction in myotonic dystrophy type 1. Int J Cardiol. 2009;137:310–3.PubMed
24.
Finsterer J, Stöllberger C, Schubert B. Acquired left ventricular noncompaction as a cardiac manifestation of neuromuscular disorders. Scand Cardiovasc J. 2008;42:25–30.PubMed
25.
Finsterer J, Stöllberger C, Gaismayer K, Janssen B. Acquired noncompaction in Duchenne muscular dystrophy. Int J Cardiol. 2006;106:420–1.PubMed
26.
Finsterer J, Stöllberger C, Schubert B. Acquired left ventricular hypertrabeculation/noncompaction in mitochondriopathy. Cardiology. 2004;102:228–30.PubMed
27.
Ciolli A, de Matteis G, Trambaiolo P, Castro A, Stingone A, Altamura G. Is Left Ventricular Noncompaction Only a Morphological Feature? A Case of Disappearance of Noncompaction after Surgical Correction of Aorto-Right Ventricular Fistula, Interventricular Septal Defect and Aortic Stenosis. J Cardiovasc Echogr. 2015;25:26–8.PubMedPubMedCentral
28.
Møller DV, Andersen PS, Hedley P, Ersbøll MK, Bundgaard H, Moolman-Smook J, et al. The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet. 2009;17:1241–9.PubMedPubMedCentral
29.
Al Senaidi K, Joshi N, Al-Nabhani M, Al-Kasbi G, Al Farqani A, Al-Thihli K, et al. Phenotypic spectrum of ALPK3-related cardiomyopathy. Am J Med Genet A. 2019;179:1235–40.PubMed
30.
Miszalski-Jamka K, Jefferies JL, Mazur W, Głowacki J, Hu J, Lazar M, Gibbs RA, Liczko J, Kłyś J, Venner E, Muzny DM, Rycaj J, Białkowski J, Kluczewska E, Kalarus Z, Jhangiani S, Al-Khalidi H, Kukulski T, Lupski JR, Craigen WJ, Bainbridge MN. Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction. Circ Cardiovasc Genet 2017;10(4). doi: 10.1161/CIRCGENETICS.117.001763.
31.
Tian T, Wang J, Wang H, Sun K, Wang Y, Jia L, et al. A low prevalence of sarcomeric gene variants in a Chinese cohort with left ventricular non-compaction. Heart Vessels. 2015;30:258–64.PubMed
32.
Finsterer J, Stöllberger C, Grassberger M, Gerger D. Noncompaction in mitochondrial myopathy: visible on microscopy but absent on macroscopic inspection. Cardiology. 2013;125:146–9.PubMed
33.
Grothoff M, Pachowsky M, Hoffmann J, Posch M, Klaassen S, Lehmkuhl L, et al. Value of cardiovascular MR in diagnosing left ventricular non-compaction cardiomyopathy and in discriminating between other cardiomyopathies. Eur Radiol. 2012;22:2699–709.PubMedPubMedCentral
34.
Boban M, Pesa V, Beck N, Manola S, Zulj M, Rotim A, et al. Supplementary Diagnostic Landmarks of Left Ventricular Non-Compaction on Magnetic Resonance Imaging. Yonsei Med J. 2018;59:63–71.PubMed
35.
36.
Stöllberger C, Blazek G, Gessner M, Bichler K, Wegner C, Finsterer J. Neuromuscular comorbidity, heart failure, and atrial fibrillation as prognostic factors in left ventricular hypertrabeculation/noncompaction. Herz. 2015;40:906–11.PubMed
37.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.PubMed
38.
Bavishi A, Lima K, Choudhury L. A New Diagnosis of Left Ventricular Non-Compaction in a Patient Presenting with Acute Heart Failure. J Radiol Case Rep. 2018;12:10–5.PubMedPubMedCentral
39.
Li J, Franke J, Pribe-Wolferts R, Meder B, Ehlermann P, Mereles D, et al. Effects of β-blocker therapy on electrocardiographic and echocardiographic characteristics of left ventricular noncompaction. Clin Res Cardiol. 2015;104:241–9.PubMed
40.
Kido K, Guglin M. Anticoagulation Therapy in Specific Cardiomyopathies: Isolated Left Ventricular Noncompaction and Peripartum Cardiomyopathy. J Cardiovasc Pharmacol Ther. 2019;24:31–6.PubMed
41.
42.
Stöllberger C, Wegner C, Finsterer J. CHADS2- and CHA2DS2VASc scores and embolic risk in left ventricular hypertrabeculation/noncompaction. J Stroke Cerebrovasc Dis. 2013;22:709–12.PubMed
43.
Stöllberger C, Finsterer J. New oral anticoagulants for stroke prevention in left ventricular hypertrabeculation/noncompaction? Int J Cardiol. 2013;168:2910–1.PubMed
44.
Sakai Y, Sato Y, Matsuo S, Imai S, Kunimasa T, Matsumoto N, et al. Perforation of the right ventricular free wall by an ICD lead in a patient with isolated noncompaction of the ventricular myocardium. Int J Cardiol. 2007;117:e104–6.PubMed
45.
Gleva MJ, Wang Y, Curtis JP, Berul CI, Huddleston CB, Poole JE. Complications Associated With Implantable Cardioverter Defibrillators in Adults With Congenital Heart Disease or Left Ventricular Noncompaction Cardiomyopathy (From the NCDR® Implantable Cardioverter-Defibrillator Registry). Am J Cardiol. 2017;120:1891–8.PubMed
46.
Bertini M, Balla C, Pavasini R, Boriani G. Efficacy of cardiac resynchronization therapy in patients with isolated ventricular noncompaction with dilated cardiomyopathy: a systematic review of the literature. J Cardiovasc Med (Hagerstown). 2018;19:324–8.
47.
Minamisawa M, Koyama J, Kozuka A, Miura T, Ebisawa S, Motoki H, et al. Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy. J Cardiol. 2016;68:431–8.PubMed
48.
Vinardell JM, Avila MD, Santana O. Isolated Left Ventricular Noncompaction Cardiomyopathy: A Transient Disease? Rev Cardiovasc Med. 2016;17:80–4.PubMed
49.
Stöllberger C, Keller H, Finsterer J. Disappearance of left ventricular hypertrabeculation/noncompaction after biventricular pacing in a patient with polyneuropathy. J Card Fail. 2007;13:211–4.PubMed
50.
Uribarri A, Rojas SV, Avsar M, Hanke JS, Napp LC, Berliner D, et al. First series of mechanical circulatory support in non-compaction cardiomyopathy: Is LVAD implantation a safe alternative? Int J Cardiol. 2015;197:128–32.PubMed
51.
52.
Epstein AE, Abraham WT, Bianco NR, Kern KB, Mirro M, Rao SV, et al. Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction. J Am Coll Cardiol. 2013;62:2000–7.PubMed
53.
54.
Stöllberger C, Finsterer J. Wearable cardioverter-defibrillator in a patient with left ventricular noncompaction/hypertrabeculation, coronary artery disease, and polyneuropathy. Ann Noninvasive Electrocardiol. 2015;20:79–81.PubMed
55.
Reuschel E, Baessler A, Stöllberger C, Finsterer J, Maier L, Fischer M, et al. Interdisciplinary management of left ventricular hypertrabeculation/noncompaction during pregnancy with a wearable defibrillator. Int J Cardiol. 2016;223:154–8.PubMed
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
Smith JGW, Owen T, Bhagwan JR, Mosqueira D, Scott E, Mannhardt I, et al. Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits. Stem Cell Reports. 2018;11:1226–43.PubMedPubMedCentral
68.
Grigoratos C, Barison A, Ivanov A, et al. Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction. JACC Cardiovasc Imaging. 2019;12:2141–51.PubMed
69.
Zhou H, Lin X, Fang L, et al. Prolonged QTc indicates the clinical severity and poor prognosis in patients with isolated left ventricular non-compaction. Int J Cardiovasc Imaging. 2017;33:2013–20.PubMed
70.
Takasaki A, Hirono K, Hata Y, Wang C, Takeda M, Yamashita JK, et al. Sarcomere gene variants act as a genetic trigger underlying the development of left ventricular noncompaction. Pediatr Res. 2018;84:733–42.PubMed
71.
Yilmaz S, Gokben S, Serdaroglu G, Eraslan C, Mancini GM, Tekin H, et al. The expanding phenotypic spectrum of ARFGEF2 gene mutation: Cardiomyopathy and movement disorder. Brain Dev. 2016;38:124–7.PubMed
72.
Hirono K, Saito K, Munkhsaikhan U, Xu F, Wang C, Lu L, et al. Familial Left Ventricular Non-Compaction Is Associated With a Rare p.V407I Variant in Bone Morphogenetic Protein 10. Circ J. 2019;83:1737–46.PubMed
73.
Lan NSR, Fietz M, Pachter N, Paul V, Playford D. A case of vascular Ehlers-Danlos Syndrome with a cardiomyopathy and multi-system involvement. Cardiovasc Pathol. 2018;35:48–51.PubMed
74.
Olgac A, Öztoprak Ü, Kasapkara ÇS, Kılıç M, Yüksel D, Derinkuyu EB, et al. A rare case of primary coenzyme Q10 deficiency due to COQ9 mutation. J Pediatr Endocrinol Metab. 2020;33:165–70.PubMed
75.
Bohrer T, Klein HG, Elert O. Left ventricular non-compaction associated with a genetic variant of the CYP2C9 gene. Heart Lung Circ. 2006;15:269–71.PubMed
76.
Fan P, Lu CX, Dong XQ, Zhu D, Yang KQ, Liu KQ, et al. A novel phenotype with splicing mutation identified in a Chinese family with desminopathy. Chin Med J (Engl). 2019;132:127–34.
77.
Williams T, Machann W, Kühler L, Hamm H, Müller-Höcker J, Zimmer M, et al. Novel desmoplakin mutation: juvenile biventricular cardiomyopathy with left ventricular non-compaction and acantholytic palmoplantar keratoderma. Clin Res Cardiol. 2011;100:1087–93.PubMedPubMedCentral
78.
Ader F, De Groote P, Réant P, Rooryck-Thambo C, Dupin-Deguine D, Rambaud C, et al. FLNC pathogenic variants in patients with cardiomyopathies: Prevalence and genotype-phenotype correlations. Clin Genet. 2019;96:317–29.PubMed
79.
Amiya E, Morita H, Hatano M, Nitta D, Hosoya Y, Maki H, et al. Fukutin gene mutations that cause left ventricular noncompaction. Int J Cardiol. 2016;222:727–9.PubMed
80.
81.
Ojala T, Nupponen I, Saloranta C, Sarkola T, Sekar P, Breilin A, et al. Fetal left ventricular noncompaction cardiomyopathy and fatal outcome due to complete deficiency of mitochondrial trifunctional protein. Eur J Pediatr. 2015;174:1689–92.PubMed
82.
Yokoyama R, Kinoshita K, Hata Y, Abe M, Matsuoka K, Hirono K, et al. A mutant HCN4 channel in a family with bradycardia, left bundle branch block, and left ventricular noncompaction. Heart Vessels. 2018;33:802–19.PubMed
83.
Codron P, Pautot V, Tassin A, Sternberg D, Letournel F, Richard P, et al. Abundant electrical myotonia and left ventricular noncompaction: Unusual features of Danon disease due to a novel mutation in LAMP2 gene. Rev Neurol (Paris). 2019;175:201–3.
84.
Hachiya A, Motoki N, Akazawa Y, Matsuzaki S, Hirono K, Hata Y, et al. Left ventricular non-compaction revealed by aortic regurgitation due to Kawasaki disease in a boy with LDB3 mutation. Pediatr Int. 2016;58:797–800.PubMed
85.
Piccolo P, Attanasio S, Secco I, Sangermano R, Strisciuglio C, Limongelli G, et al. MIB2 variants altering NOTCH signalling result in left ventricle hypertrabeculation/non-compaction and are associated with Ménétrier-like gastropathy. Hum Mol Genet. 2017;26:33–43.PubMed
86.
Eldomery MK, Akdemir ZC, Vögtle FN, Charng WL, Mulica P, Rosenfeld JA, et al. MIPEP recessive variants cause a syndrome of left ventricular non-compaction, hypotonia, and infantile death. Genome Med. 2016;8:106.PubMedPubMedCentral
87.
Prada CE, Jefferies JL, Grenier MA, Huth CM, Page KI, Spicer RL, et al. Malonyl coenzyme A decarboxylase deficiency: early dietary restriction and time course of cardiomyopathy. Pediatrics. 2012;130:e456–60.PubMed
88.
García-García J, Fernández-García MA, Blanco-Arias P, Díaz-Maroto-Cicuendez MI, Salmerón-Martínez F, Hidalgo-Olivares VM, et al. Non-compaction cardiomyopathy and early respiratory failure in an adult symptomatic female carrier of centronuclear myopathy caused by a MTM1 mutation. Neuromuscul Disord. 2018;28:952–5.PubMed
89.
Hirono K, Hata Y, Ibuki K, Yoshimura N. Familial Ebstein's anomaly, left ventricular noncompaction, and ventricular septal defect associated with an MYH7 mutation. J Thorac Cardiovasc Surg. 2014;148:e223–6.PubMed
90.
91.
Ouyang P, Saarel E, Bai Y, Luo C, Lv Q, Xu Y, et al. A de novo mutation in NKX2.5 associated with atrial septal defects, ventricular noncompaction, syncope and sudden death. Clin Chim Acta. 2011;412:170–5.PubMed
92.
Bainbridge MN, Davis EE, Choi WY, Dickson A, Martinez HR, Wang M, et al. Loss of Function Mutations in NNT Are Associated With Left Ventricular Noncompaction. Circ Cardiovasc Genet. 2015;8:544–52.PubMedPubMedCentral
93.
Brndiarova M, Antonyova M, Dedinska I, Havlicekova Z, Jesenak M. Nephronophthisis type I, left ventricular non-compaction cardiomyopathy and reduced cilia motility-atypical manifestations of one disease. J Nephrol. 2020;33:183–6.PubMed
94.
Rowland TJ, Graw SL, Sweet ME, Gigli M, Taylor MR, Mestroni L. Obscurin Variants in Patients With Left Ventricular Noncompaction. J Am Coll Cardiol. 2016;68:2237–8.PubMedPubMedCentral
95.
Lubrano R, Versacci P, Guido G, Bellelli E, Andreoli G, Elli M. Might there be an association between polycystic kidney disease and noncompaction of the ventricular myocardium? Nephrol Dial Transplant. 2009;24:3884–6.PubMed
96.
Ramond F, Janin A, Di Filippo S, Chanavat V, Chalabreysse L, Roux-Buisson N, et al. Homozygous PKP2 deletion associated with neonatal left ventricle noncompaction. Clin Genet. 2017;91:126–30.PubMed
97.
Villa CR, Ryan TD, Collins JJ, Taylor MD, Lucky AW, Jefferies JL. Left ventricular non-compaction cardiomyopathy associated with epidermolysis bullosa simplex with muscular dystrophy and PLEC1 mutation. Neuromuscul Disord. 2015;25:165–8.PubMed
98.
Abdullah S, Hawkins C, Wilson G, Yoon G, Mertens L, Carter MT, et al. Noncompaction cardiomyopathy in an infant with Walker-Warburg syndrome. Am J Med Genet A. 2017;173:3082–6.PubMed
99.
Delplancq G, Tarris G, Vitobello A, Nambot S, Sorlin A, Philippe C, et al. Cardiomyopathy due to PRDM16 mutation: First description of a fetal presentation, with possible modifier genes. Am J Med Genet C Semin Med Genet. 2020;184:129–35.PubMed
100.
Kayvanpour E, Sedaghat-Hamedani F, Gi WT, Tugrul OF, Amr A, Haas J, et al. Clinical and genetic insights into non-compaction: a meta-analysis and systematic review on 7598 individuals. Clin Res Cardiol. 2019;108:1297–308.PubMed
101.
Nozaki Y, Kato Y, Uike K, Yamamura K, Kikuchi M, Yasuda M, et al. Co-Phenotype of Left Ventricular Non-Compaction Cardiomyopathy and Atypical Catecholaminergic Polymorphic Ventricular Tachycardia in Association With R169Q, a Ryanodine Receptor Type 2 Missense Mutation. Circ J. 2020;84:226–34.PubMed
102.
Jain-Ghai S, Cameron JM, Al Maawali A, Blaser S, MacKay N, Robinson B, et al. Complex II deficiency--a case report and review of the literature. Am J Med Genet A. 2013;161A:285–94.PubMed
103.
Wenger TL, Chow P, Randle SC, Rosen A, Birgfeld C, Wrede J, et al. Novel findings of left ventricular non-compaction cardiomyopathy, microform cleft lip and poor vision in patient with SMC1A-associated Cornelia de Lange syndrome. Am J Med Genet A. 2017;173:414–20.PubMed
104.
Hirono K, Ichida F, Nishio N, Ogawa-Tominaga M, Fushimi T, Feichtinger RG, et al. Mitochondrial complex deficiency by novel compound heterozygous TMEM70 variants and correlation with developmental delay, undescended testicle, and left ventricular noncompaction in a Japanese patient: A case report. Clin Case Rep. 2019;7:553–7.PubMedPubMedCentral
105.
Fujino M, Tsuda E, Hirono K, Nakata M, Ichida F, Hata Y, et al. The TNNI3 Arg192His mutation in a 13-year-old girl with left ventricular noncompaction. J Cardiol Cases. 2018;18:33–6.PubMedPubMedCentral
106.
Hastings R, de Villiers CP, Hooper C, Ormondroyd L, Pagnamenta A, Lise S, et al. Combination of Whole Genome Sequencing, Linkage, and Functional Studies Implicates a Missense Mutation in Titin as a Cause of Autosomal Dominant Cardiomyopathy With Features of Left Ventricular Noncompaction. Circ Cardiovasc Genet. 2016;9:426–35.PubMedPubMedCentral
Metadata
Title
Left Ventricular Noncompaction Syndrome: Genetic Insights and Therapeutic Perspectives
Authors
Josef Finsterer
Claudia Stöllberger
Publication date
01-09-2020
Publisher
Springer US
Published in
Current Cardiology Reports / Issue 9/2020
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-020-01339-5

Other articles of this Issue 9/2020

Current Cardiology Reports 9/2020 Go to the issue

Myocardial Disease (A Abbate and G Sinagra, Section Editors)

Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach

Cardiac PET, CT, and MRI (P Schoenhagen and P-H Chen, Section Editor)

Radiomics in Echocardiography: Deep Learning and Echocardiographic Analysis

Management of Acute Coronary Syndromes (H Jneid, Section Editor)

Ethnic and Racial Disparities in Acute Myocardial Infarction

Echocardiography (JM Gardin and AH Waller, Section Editor)

The Role of Artificial Intelligence in Echocardiography

Heart Failure (HJ Eisen, Section Editor)

Heart Failure with Preserved Ejection Fraction—a Concise Review

Nuclear Cardiology (V Dilsizian, Section Editor)

Detection of Native and Prosthetic Valve Endocarditis: Incremental Attributes of Functional FDG PET/CT over Morphologic Imaging

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits